Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Vinay S Eligar"'
1
A case of pituitary apoplexy masquerading as subarachnoid hemorrhage
Autor: Anna DeLloyd, Vinay S Eligar, J. S. Davies, Maitrayee Choudhury
Publikováno v: Clinical Case Reports
Key Clinical Message Pituitary apoplexy may cause xanthochromia and mimic the clinical presentation of subarachnoid hemorrhage.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e96bb294d5ae1878e890e98ce69809d2
https://doi.org/10.1002/ccr3.488
Zobrazit plný text záznamu
3
Insulin degludec in Type 1 diabetes
Autor: Vinay S Eligar, Stephen C Bain
Publikováno v: Clinical Investigation. 3:943-950
Long-acting analog insulins have been increasingly used in preference to neutral protamine hagedorn insulins since their launch some 10 years ago. Although the achieved hemoglobin A1c reduction is similar, a lower incidence of nocturnal and symptomat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::30aca00990fe2b1fd2c653d696c8abb3
https://doi.org/10.4155/cli.13.80
Zobrazit plný text záznamu
7
Late presentation of hyperandrogenism in pregnancy: clinical features and differential diagnosis
Autor: Jyothish Govindan, Gautam Das, D Aled Rees, Vinay S Eligar
Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Summary Background: Hyperandrogenic states in pregnancy are rare but arise most commonly due to new-onset ovarian pathology in pregnancy. We describe the case of a young woman who presented in the latter half of her pregnancy with features of hyperan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af808275489c8081e69b58788151a5f5
https://pubmed.ncbi.nlm.nih.gov/24616776
Zobrazit plný text záznamu
8
A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment
Autor: Vinay S Eligar, Stephen C Bain
Publikováno v: Drug Design, Development and Therapy
Sitagliptin is the first dipeptidylpeptidase-4 inhibitor to be used in the management of type 2 diabetes. It is widely used as an add-on therapy to ongoing management or as monotherapy where it is deemed necessary. It has been found to be beneficial
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2398fb1cee002d5e5b480def8607e257
https://pubmed.ncbi.nlm.nih.gov/24039399
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje